CIK 0001377121 · Large accelerated filer
Protagonist Therapeutics, Inc
Sign in to watch- Ticker
- PTGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980505495
- Phone
- (510) 474-0170
- Business address
- 7707 GATEWAY BLVD., SUITE 140, NEWARK, CA, 94560-1160
- Former names
- Protagonist Therapeutics Inc, Protagonist Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $26,552,861
- in 2 filings, $26.6M under 10b5-1 plans
Net −$26,552,861. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-30 | Ali Asif Chief Financial Officer | Sale 10b5-1 | −12,595 | $141.77 | $1.8M | 105,037 |
| 2026-09-30 | Ali Asif Chief Financial Officer | Sale 10b5-1 | −46,034 | $141.78 | $6.5M | 59,003 |
| 2026-09-10 | PATEL DINESH V PH D President and CEO | Sale 10b5-1 | −7,278 | $144.10 | $1.0M | 522,968 |
| 2026-09-09 | PATEL DINESH V PH D President and CEO | Sale 10b5-1 | −63,548 | $146.18 | $9.3M | 522,968 |
| 2026-09-08 | PATEL DINESH V PH D President and CEO | Sale 10b5-1 | −54,174 | $145.87 | $7.9M | 522,968 |
| 2026-08-11 | PATEL DINESH V PH D President and CEO | Sale 10b5-1 | −34,239 | $148.52 | $5.1M | 523,478 |
| 2026-08-10 | PATEL DINESH V PH D President and CEO | Sale 10b5-1 | −65,761 | $149.11 | $9.8M | 523,478 |
| 2026-06-23 | Waddill William D. Director | Sale 10b5-1 | −9,000 | $117.94 | $1.1M | 7,825 |
| 2026-06-10 | Waddill William D. Director | Sale 10b5-1 | −9,000 | $107.68 | $969K | 7,825 |
| 2026-05-29 | Waddill William D. Director | Sale 10b5-1 | −9,000 | $99.64 | $897K | 7,825 |
| 2026-05-12 | PATEL DINESH V PH D President and CEO | Sale 10b5-1 | −75,000 | $100.12 | $7.5M | 523,478 |
| 2026-05-12 | PATEL DINESH V PH D President and CEO | Sale | −75,000 | $100.12 | $7.5M | 523,478 |
| 2026-05-08 | Giraudo Bryan Director | Sale | −6,000 | $100.00 | $600K | 0 |
| 2026-05-08 | Giraudo Bryan Director | Sale | −5,130 | $100.00 | $513K | 12,695 |
| 2026-05-07 | Giraudo Bryan Director | Sale | −36,000 | $100.14 | $3.6M | 27,825 |
| 2026-05-07 | Giraudo Bryan Director | Sale | −12,000 | $100.07 | $1.2M | 6,000 |
| 2026-04-20 | Ali Asif Chief Financial Officer | Sale | −1,750 | $105.47 | $185K | 59,003 |
| 2026-03-26 | MOLINA ARTURO MD Chief Medical Officer | Sale | −15,000 | $104.79 | $1.6M | 84,115 |
| 2026-03-26 | SELICK HAROLD E Director | Sale | −24,000 | $105.00 | $2.5M | 60,845 |
| 2026-03-26 | Ali Asif Chief Financial Officer | Sale | −24,765 | $104.24 | $2.6M | 60,753 |
Page 1 of 7 · 127 trades